BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai S, Zhou X, Wang B, Wang Q, Fu Y, Chen T, Wan T, Yu Y, Cao X. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8(+) CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. J Mol Med (Berl) 2006;84:1067-76. [PMID: 17016692 DOI: 10.1007/s00109-006-0102-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 You L, Mao L, Wei J, Jin S, Yang C, Liu H, Zhu L, Qian W. The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses. J Hematol Oncol 2017;10:165. [PMID: 29058602 DOI: 10.1186/s13045-017-0534-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
2 Donoso-quezada J, Ayala-mar S, González-valdez J. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review. Critical Reviews in Biotechnology 2020;40:804-20. [DOI: 10.1080/07388551.2020.1785385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
3 Chulpanova DS, Kitaeva KV, James V, Rizvanov AA, Solovyeva VV. Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment. Front Immunol 2018;9:1534. [PMID: 30018618 DOI: 10.3389/fimmu.2018.01534] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 13.5] [Reference Citation Analysis]
4 Zhang J, Zhang Y, Luo C, Xia Y, Chen H, Wu X. Glycosyl-Phosphatidylinositol-Anchored Interleukin-2 Expressed on Tumor-Derived Exosomes Induces Antitumor Immune Response in Vitro. Tumori 2010;96:452-9. [DOI: 10.1177/030089161009600313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
5 Bhatti JS, Vijayvergiya R, Singh B, Bhatti GK. Exosome nanocarriers. Nanoarchitectonics in Biomedicine. Elsevier; 2019. pp. 189-218. [DOI: 10.1016/b978-0-12-816200-2.00008-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Xu HM. Th1 cytokine-based immunotherapy for cancer. Hepatobiliary Pancreat Dis Int 2014;13:482-94. [PMID: 25308358 DOI: 10.1016/s1499-3872(14)60305-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
7 Zhu M, Li Y, Shi J, Feng W, Nie G, Zhao Y. Exosomes as Extrapulmonary Signaling Conveyors for Nanoparticle-Induced Systemic Immune Activation. Small 2012;8:404-12. [DOI: 10.1002/smll.201101708] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 6.2] [Reference Citation Analysis]
8 Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871:455-468. [PMID: 31047959 DOI: 10.1016/j.bbcan.2019.04.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 26.0] [Reference Citation Analysis]
9 Li Q, Cai S, Li M, Salma KI, Zhou X, Han F, Chen J, Huyan T. Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy. Int J Nanomedicine 2021;16:5395-409. [PMID: 34408415 DOI: 10.2147/IJN.S313912] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xie Y, Bai O, Zhang H, Yuan J, Zong S, Chibbar R, Slattery K, Qureshi M, Wei Y, Deng Y. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med. 2010;14:2655-2666. [PMID: 19627400 DOI: 10.1111/j.1582-4934.2009.00851.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 7.1] [Reference Citation Analysis]
11 Webber J, Yeung V, Clayton A. Extracellular vesicles as modulators of the cancer microenvironment. Semin Cell Dev Biol. 2015;40:27-34. [PMID: 25662446 DOI: 10.1016/j.semcdb.2015.01.013] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 12.9] [Reference Citation Analysis]
12 Zhao Y, Liu L, Sun R, Cui G, Guo S, Han S, Li Z, Bai T, Teng L. Exosomes in cancer immunoediting and immunotherapy. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2021.12.001] [Reference Citation Analysis]
13 Chen W, Jiang J, Xia W, Huang J. Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective. J Immunol Res 2017;2017:1073947. [PMID: 28642882 DOI: 10.1155/2017/1073947] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
14 Chen T, Guo J, Han C, Yang M, Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol 2009;182:1449-59. [PMID: 19155492 DOI: 10.4049/jimmunol.182.3.1449] [Cited by in Crossref: 145] [Cited by in F6Publishing: 146] [Article Influence: 11.2] [Reference Citation Analysis]
15 H Rashed M, Bayraktar E, K Helal G, Abd-Ellah MF, Amero P, Chavez-Reyes A, Rodriguez-Aguayo C. Exosomes: From Garbage Bins to Promising Therapeutic Targets. Int J Mol Sci 2017;18:E538. [PMID: 28257101 DOI: 10.3390/ijms18030538] [Cited by in Crossref: 196] [Cited by in F6Publishing: 180] [Article Influence: 39.2] [Reference Citation Analysis]
16 Parayath NN, Padmakumar S, Amiji MM. Extracellular vesicle-mediated nucleic acid transfer and reprogramming in the tumor microenvironment. Cancer Letters 2020;482:33-43. [DOI: 10.1016/j.canlet.2020.04.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Gulei D, Irimie AI, Cojocneanu-petric R, Schultze JL, Berindan-neagoe I. Exosomes—Small Players, Big Sound. Bioconjugate Chem 2018;29:635-48. [DOI: 10.1021/acs.bioconjchem.8b00003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
18 Huang F, Wan J, Hao S, Deng X, Chen L, Ma L. TGF-β1-silenced leukemia cell-derived exosomes target dendritic cells to induce potent anti-leukemic immunity in a mouse model. Cancer Immunol Immunother 2017;66:1321-31. [PMID: 28601924 DOI: 10.1007/s00262-017-2028-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
19 Heckman KL, Schenk EL, Radhakrishnan S, Pavelko KD, Hansen MJ, Pease LR. Fast-tracked CTL: rapid induction of potent anti-tumor killer T cells in situ. Eur J Immunol 2007;37:1827-35. [PMID: 17549735 DOI: 10.1002/eji.200637002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
20 Nicolini A, Ferrari P, Biava PM. Exosomes and Cell Communication: From Tumour-Derived Exosomes and Their Role in Tumour Progression to the Use of Exosomal Cargo for Cancer Treatment. Cancers (Basel) 2021;13:822. [PMID: 33669294 DOI: 10.3390/cancers13040822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Yang Y, Chen Y, Zhang F, Zhao Q, Zhong H. Increased anti-tumour activity by exosomes derived from doxorubicin-treated tumour cells via heat stress. Int J Hyperthermia 2015;31:498-506. [PMID: 25955015 DOI: 10.3109/02656736.2015.1036384] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
22 Alsagaby SA. Molecular Insights into the Potential of Extracellular Vesicles Released from Mesenchymal Stem Cells and Other Cells in the Therapy of Hematologic Malignancies. Stem Cells Int 2021;2021:6633386. [PMID: 33679988 DOI: 10.1155/2021/6633386] [Reference Citation Analysis]
23 Kanlikilicer P, Rashed MH, Bayraktar R, Mitra R, Ivan C, Aslan B, Zhang X, Filant J, Silva AM, Rodriguez-Aguayo C, Bayraktar E, Pichler M, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G. Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells. Cancer Res 2016;76:7194-207. [PMID: 27742688 DOI: 10.1158/0008-5472.CAN-16-0714] [Cited by in Crossref: 75] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
24 Zhong H, Yang Y, Ma S, Xiu F, Cai Z, Zhao H, Du L. Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients. Int J Hyperthermia. 2011;27:604-611. [PMID: 21846196 DOI: 10.3109/02656736.2011.564598] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
25 Yang C, Robbins PD. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol. 2011;2011:842849. [PMID: 22190973 DOI: 10.1155/2011/842849] [Cited by in Crossref: 140] [Cited by in F6Publishing: 171] [Article Influence: 12.7] [Reference Citation Analysis]
26 Manning S, Danielson KM. The immunomodulatory role of tumor-derived extracellular vesicles in colorectal cancer. Immunol Cell Biol. 2018;. [PMID: 29575270 DOI: 10.1111/imcb.12038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
27 Zhu M, Tian X, Song X, Li Y, Tian Y, Zhao Y, Nie G. Nanoparticle-induced exosomes target antigen-presenting cells to initiate Th1-type immune activation. Small 2012;8:2841-8. [PMID: 22674628 DOI: 10.1002/smll.201200381] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
28 Wan M, Ning B, Spiegel S, Lyon CJ, Hu TY. Tumor-derived exosomes (TDEs): How to avoid the sting in the tail. Med Res Rev 2020;40:385-412. [PMID: 31318078 DOI: 10.1002/med.21623] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
29 De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015;6:203. [PMID: 25999947 DOI: 10.3389/fimmu.2015.00203] [Cited by in Crossref: 293] [Cited by in F6Publishing: 306] [Article Influence: 41.9] [Reference Citation Analysis]
30 Hao S, Moyana T, Xiang J. Review: cancer immunotherapy by exosome-based vaccines. Cancer Biother Radiopharm 2007;22:692-703. [PMID: 17979572 DOI: 10.1089/cbr.2007.368-R] [Cited by in Crossref: 42] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
31 Kothandan VK, Kothandan S, Kim DH, Byun Y, Lee YK, Park IK, Hwang SR. Crosstalk between Stress Granules, Exosomes, Tumour Antigens, and Immune Cells: Significance for Cancer Immunity. Vaccines (Basel) 2020;8:E172. [PMID: 32276342 DOI: 10.3390/vaccines8020172] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
32 Guo D, Chen Y, Wang S, Yu L, Shen Y, Zhong H, Yang Y. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6. Immunology 2018;154:132-43. [PMID: 29197065 DOI: 10.1111/imm.12874] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
33 Qin M, Du G, Sun X. Biomimetic cell-derived nanocarriers for modulating immune responses. Biomater Sci 2020;8:530-43. [DOI: 10.1039/c9bm01444f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
34 Imani Fooladi AA, Halabian R, Mahdavi M, Amin M, Mahmoodzadeh Hosseini H. Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy. Tumor Biol 2016;37:739-48. [DOI: 10.1007/s13277-015-3877-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sadovska L, Santos CB, Kalniņa Z, Linē A. Biodistribution, Uptake and Effects Caused by Cancer-Derived Extracellular Vesicles. J Circ Biomark 2015;4:2. [PMID: 28936238 DOI: 10.5772/60522] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
36 Urbanelli L, Magini A, Buratta S, Brozzi A, Sagini K, Polchi A, Tancini B, Emiliani C. Signaling pathways in exosomes biogenesis, secretion and fate. Genes (Basel). 2013;4:152-170. [PMID: 24705158 DOI: 10.3390/genes4020152] [Cited by in Crossref: 185] [Cited by in F6Publishing: 192] [Article Influence: 20.6] [Reference Citation Analysis]
37 Yong T, Li X, Wei Z, Gan L, Yang X. Extracellular vesicles-based drug delivery systems for cancer immunotherapy. Journal of Controlled Release 2020;328:562-74. [DOI: 10.1016/j.jconrel.2020.09.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
38 Wang X, Zhou Y, Ding K. Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (Review). Int J Oncol 2021;59:44. [PMID: 34013358 DOI: 10.3892/ijo.2021.5224] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Xie Y, Bai O, Zhang H, Li W, Xiang J. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity. Cancer Biother Radiopharm 2010;25:21-8. [PMID: 20187793 DOI: 10.1089/cbr.2009.0714] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
40 Yang C, Kim SH, Bianco NR, Robbins PD. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One 2011;6:e22517. [PMID: 21829629 DOI: 10.1371/journal.pone.0022517] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 6.9] [Reference Citation Analysis]
41 Patras L, Banciu M. Intercellular Crosstalk Via Extracellular Vesicles in Tumor Milieu as Emerging Therapies for Cancer Progression. CPD 2019;25:1980-2006. [DOI: 10.2174/1381612825666190701143845] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
42 Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl). 2013;91:431-437. [PMID: 23519402 DOI: 10.1007/s00109-013-1020-6] [Cited by in Crossref: 462] [Cited by in F6Publishing: 491] [Article Influence: 51.3] [Reference Citation Analysis]
43 Donoso-Quezada J, Guajardo-Flores D, González-Valdez J. Enhanced exosome-mediated delivery of black bean phytochemicals (Phaseolus vulgaris L.) for cancer treatment applications. Biomed Pharmacother 2020;131:110771. [PMID: 33152932 DOI: 10.1016/j.biopha.2020.110771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
44 Chen T, Guo J, Yang M, Zhu X, Cao X. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol. 2011;186:2219-2228. [PMID: 21242526 DOI: 10.4049/jimmunol.1002991] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 12.7] [Reference Citation Analysis]
45 Bhargava A, Mishra D, Banerjee S, Mishra PK. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation. Immunotherapy 2012;4:703-18. [PMID: 22853757 DOI: 10.2217/imt.12.40] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
46 Gilligan KE, Dwyer RM. Engineering Exosomes for Cancer Therapy. Int J Mol Sci 2017;18:E1122. [PMID: 28538671 DOI: 10.3390/ijms18061122] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 17.8] [Reference Citation Analysis]
47 Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer. Mol Ther 2008. [DOI: 10.1038/sj.mt.6300407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Guo X, Qiu W, Wang J, Liu Q, Qian M, Wang S, Zhang Z, Gao X, Chen Z, Guo Q, Xu J, Xue H, Li G. Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-92a/Prkar1a pathways. Int J Cancer 2019;144:3111-26. [PMID: 30536597 DOI: 10.1002/ijc.32052] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
49 Huang MB, Wu JY, Lillard J, Bond VC. SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells. Oncotarget 2019;10:5419-38. [PMID: 31534628 DOI: 10.18632/oncotarget.27138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Gajos-Michniewicz A, Duechler M, Czyz M. MiRNA in melanoma-derived exosomes. Cancer Lett 2014;347:29-37. [PMID: 24513178 DOI: 10.1016/j.canlet.2014.02.004] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 8.8] [Reference Citation Analysis]
51 Bobrie A, Colombo M, Raposo G, Théry C. Exosome Secretion: Molecular Mechanisms and Roles in Immune Responses. Traffic 2011;12:1659-68. [DOI: 10.1111/j.1600-0854.2011.01225.x] [Cited by in Crossref: 594] [Cited by in F6Publishing: 607] [Article Influence: 54.0] [Reference Citation Analysis]
52 Chaput N, Théry C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 2011;33:419-40. [PMID: 21174094 DOI: 10.1007/s00281-010-0233-9] [Cited by in F6Publishing: 308] [Reference Citation Analysis]
53 Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-593. [PMID: 19498381 DOI: 10.1038/nri2567] [Cited by in Crossref: 2412] [Cited by in F6Publishing: 2406] [Article Influence: 185.5] [Reference Citation Analysis]
54 Stremersch S, De Smedt SC, Raemdonck K. Therapeutic and diagnostic applications of extracellular vesicles. J Control Release. 2016;244:167-183. [PMID: 27491882 DOI: 10.1016/j.jconrel.2016.07.054] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 12.7] [Reference Citation Analysis]
55 Liu Y, Gu Y, Cao X. The exosomes in tumor immunity. Oncoimmunology. 2015;4:e1027472. [PMID: 26405598 DOI: 10.1080/2162402x.2015.1027472] [Cited by in Crossref: 109] [Cited by in F6Publishing: 79] [Article Influence: 15.6] [Reference Citation Analysis]
56 Vasir B, Wu Z, Crawford K, Rosenblatt J, Zarwan C, Bissonnette A, Kufe D, Avigan D. Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells. J Immunol 2008;181:808-21. [PMID: 18566447 DOI: 10.4049/jimmunol.181.1.808] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
57 Carrière J, Barnich N, Nguyen HT. Exosomes: From Functions in Host-Pathogen Interactions and Immunity to Diagnostic and Therapeutic Opportunities. Rev Physiol Biochem Pharmacol 2016;172:39-75. [PMID: 27600934 DOI: 10.1007/112_2016_7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
58 Yang Z, Ma Y, Zhao H, Yuan Y, Kim BYS. Nanotechnology platforms for cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1590. [PMID: 31696664 DOI: 10.1002/wnan.1590] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
59 Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782-790. [PMID: 18362931 DOI: 10.1038/mt.2008.1] [Cited by in Crossref: 412] [Cited by in F6Publishing: 408] [Article Influence: 29.4] [Reference Citation Analysis]